Genomic Valley Biotech Ltd — Updates, 07-08-2025: Company Update

Genomic Valley Biotech's board approved the financial results for the quarter ended June 30, 2025. The company reported revenue of Rs 61,64,660 and a profit of Rs 2,46,531 for the period. This compares to a profit of Rs 12,75,903 in the same quarter last year, indicating a decline in profitability. To bolster governance, the board appointed M/s. SBR & Co. LLP as Secretarial Auditors for FY25-30 and Mr. Navjyoti Kumar Jha as Internal Auditor for FY25-26. Additionally, Mr. Yogesh Agrawal was re-appointed as Chairman & Managing Director for a five-year term starting September 7, 2025, ensuring stable leadership.